Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors

Published:2018-03 Issue:3 Volume:47 Page:326-331
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Philips Prejesh,Kooby David A.,Maithel Shishir,Merchant Nipun B.,Weber Sharon M.,Winslow Emily R.,Ahmad Syed,Kim Hong J.,Scoggins Charles R.,McMasters Kelly M.,Martin Robert C.G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Cancer statistics, 2010;CA Cancer J Clin,2010

2. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma;Endocr Relat Cancer,2009

3. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution;Clin Cancer Res,2008

4. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours;Ann Oncol,2008

5. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate;Am J Surg Pathol,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcomatoid carcinoma of the pancreas (Review);Oncology Letters;2024-08-05

2. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management;Baylor University Medical Center Proceedings;2023-12-20

3. Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy;Frontiers in Oncology;2023-06-27

4. Neuroendocrine Neoplasms;Tumors of the Pancreas;2023-03

5. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors;Surgical Pathology Clinics;2022-09